Riskpilot← Back to searchSign inGet full accessHELSEPARTNER AS
ASActiveOrg 926402579Trondheimsveien 100, 0565 OsloGeneral medical practice activities · NACE 8621Est. 20211 employees
Revenue 2025
NOK 3M
+19% vs 2024
EBITDA margin
24.9%
+155% vs 2024
Equity ratio
18.1%
Financial strength
Net profit 2025
NOK 655K
+198% vs 2024
| Revenue | NOK 3M | +19% |
| EBITDA | NOK 737K | +155% |
| Net profit | NOK 655K | +198% |
| Total assets | NOK 949K | +69% |
| Equity | NOK 172K | +158% |
| Employees | 1 | — |
Legal name
HELSEPARTNER AS
Org number
926402579
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
18. januar 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Legevirksomhet, bedriftshelsetjeneste, hms-tjenester, helseattester, ultralyd, fysioterapi, psykolog og annen relatert virksomhet
Address
Trondheimsveien 100, 0565 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 228 | 430 | 1 046 | 2 485 | 2 965 |
| Staff expenses | −40 | −97 | −627 | −1 382 | −1 366 |
| EBITDA | −9 | 17 | 234 | 288 | 737 |
| Depreciation & amort. | −0 | −0 | −0 | −16 | −21 |
| EBIT | −9 | 17 | 234 | 273 | 716 |
| Net financials | 0 | 0 | 0 | −0 | −0 |
| Profit before tax | −9 | 17 | 234 | 273 | 716 |
| Tax | −0 | −0 | 1 | 53 | 61 |
| Net profit | −9 | 17 | 233 | 220 | 655 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 31 | 89 | 458 | 563 | 949 |
| Equity | 15 | 33 | 66 | 67 | 172 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 16 | 56 | 392 | 496 | 778 |
| Total debt | 16 | 56 | 392 | 496 | 778 |
EBITDA margin
24.9%
This company
15.8%
Market median
+58% vs market
20212025
Equity ratio
18.1%
This company
38.2%
Market median
-53% vs market
20212025
Return on equity
381.2%
This company
18.4%
Market median
+1972% vs market
20212025
Net profit margin
22.1%
This company
8.1%
Market median
+173% vs market
20212025
Asset turnover
3.12×
This company
1.12×
Market median
+179% vs market
20212025
Debt / equity
4.52×
This company
0.62×
Market median
-629% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HB Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HELSEPARTNER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hossein Banitalebi | Chief Executive Officer | 0 companies |
| Kjersti-Ann Kjellstrøm | Board of Directors | 0 companies |
| Alexandra Victoria Veum Søhoel | Board of Directors | 0 companies |